Details for Patent: 4,686,214
✉ Email this page to a colleague
Summary for Patent: 4,686,214
| Title: | Anti-inflammatory compounds for ophthalmic use |
| Abstract: | Anti-inflammatory compounds and a method of treating inflamed ocular tissue utilizing these compounds are described. The steroidal actives are advantageously characterized in that they do not cause any significant increase in intraocular pressure during chronic use. |
| Inventor(s): | John J. Boltralik |
| Assignee: | Alcon Research LLC |
| Application Number: | US06/792,992 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 4,686,214
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,686,214
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 594427 | ⤷ Start Trial | |||
| Australia | 6885787 | ⤷ Start Trial | |||
| European Patent Office | 0280797 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
